Top Cannabis News & Trends: Advocate, Educate & Inspire

The cannabis landscape is evolving quickly in spring 2026. At MiCannaCast, we’re committed to advocate for fair policies, educate our community and inspire positive change. Here are the topics trending now—and why they matter.

Rescheduling to Schedule III: Policy & Patient Rights

The biggest headline in April came when Acting Attorney General Todd Blanche signed an order moving certain state‑licensed cannabis products to Schedule III. This change prompted the ATF to publish a draft of the Firearms Transaction Record (Form 4473) that removes the explicit reference to marijuana and clarifies that medical cannabis products authorized under Schedule III would no longer count as a controlled substance. For more details, see the Source. Advocacy groups note that if adopted, these revisions could mean state‑legal medical patients would no longer have to choose between their medicine and their right to bear arms.

However, the ATF’s draft is not yet final; the Justice Department’s rescheduling hearings and public comment period extend through July 7. To support patient rights, submit a comment and encourage friends and family to do the same.

Toad Venom Returns to the Spotlight

After dominating headlines in 2025, the Toad Venom strain is trending again. New clone drops and limited releases are driving up prices and reviving debates about authenticity. Social media buzz from events like California’s “Biggest Clone Release Weekend” and Michigan’s Bring Your Best Bag & Dab suggests Toad Venom remains a fan favourite, but critics warn of mislabelling and counterfeit genetics. If you’re curious, purchase from licensed dispensaries and verify lab reports.

Medical Patients’ Right to Bear Arms: An Ongoing Fight

Another major story is the ongoing court battle over federal restrictions that bar cannabis consumers from owning firearms. In January 2026, the Eleventh Circuit Court of Appeals revived a lawsuit brought by Florida medical marijuana patients, ruling that the government failed to justify a categorical ban and allowing the case to proceed. You can read more in this Source. Meanwhile, marijuana policy advocates point out that the federal Gun Control Act still prohibits users from possessing firearms, while the Marijuana Policy Project calls for reforms to end this discriminatory policy—see their overview Source.

Combined with the potential Schedule III reclassification, these developments could mark the beginning of the end for the federal gun ban on cannabis patients. Stay tuned—and stay engaged.

How to Advocate, Educate & Inspire

• Advocate: Submit a comment on the ATF’s draft Form 4473 and attend local public hearings. Support groups that fight for patient rights and equitable cannabis policies.
• Educate: Share accurate information about rescheduling, safety testing and consumer rights. Host listening sessions, book clubs or panel discussions.
• Inspire: Volunteer at community events, celebrate cannabis pioneers and lift up brands that promote sustainability and equity. Your voice matters.

Key Takeaways

• Schedule III cannabis is on the horizon: The Department of Justice’s rescheduling order could remove some federal barriers.
• Toad Venom hype persists: New clone releases and social buzz keep this controversial strain in the spotlight.
• Gun rights for patients remain unresolved: A federal appeals court is revisiting the constitutionality of the ban—watch this space.
• You can make a difference: Comment on pending regulations and help educate your community.